New avenues for the treatment of immunotherapy-resistant pancreatic cancer

doi:10.4251/wjgo.v16.i4.1134

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2704)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

1868

Figures (1-2)

170

Tables (1-2)

171

Sum=2272

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

239

Sum=318

Apr 15, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1134-1153
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1134

Full Size Figure Download Figure

Figure 1 Simplified scheme of the tumor microenvironment. PSCs: Pancreatic stellate cells; CXCL2: C-X-C chemokine ligand 2; iCAFs: Inflammatory cancer-associated fibroblasts; apCAF: Antigen-presenting cancer-associated fibroblast; ECM: Extracellular matrix; TAM: Tumor-associated macrophage; MHC II: Major histocompatibility complex class II; IL: Interleukin; TGF: Transforming growth factor.

Citation: Silva LGO, Lemos FFB, Luz MS, Rocha Pinheiro SL, Calmon MDS, Correa Santos GL, Rocha GR, de Melo FF. New avenues for the treatment of immunotherapy-resistant pancreatic cancer. World J Gastrointest Oncol 2024; 16(4): 1134-1153
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1134.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1134